Alessandra Romagnani

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial.

Angela Damato, Riziero Esposito Abate, Simona Tessitore

Pageof 1

Frequent Collaborators

1 joint publications

Angela Damato

1 joint publications

Dario Righelli

1 joint publications

Elisa Giommoni

1 joint publications

Sara Lonardi